Yipinhong announced that recently, Guangzhou Lianrui Pharmaceutical Co., Ltd., a wholly-owned subsidiary of the company, received the “Drug Registration Certificate” for the dry suspension of etrapepam ethanolamine approved by the State Drug Administration. The specification is 25 mg, the drug is valid for 24 months, and the approval number of Sinopharm is H20266097. The drug is registered according to the 3 categories of chemicals and is deemed to have passed the consistency evaluation.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.